IRCT20150914024017N1招募中3 期
the efficacy of Interferon beta 1 a (ReciGen) in treatment of patients with Covid-19 in Sina Hospital Emergency Department
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •patients who are diagnosed to have covid-19 based on Chest Ct Scan
- •patients being admitted to emergency room based on local guidelines
- •age 18 years or loder
排除标准
- •breast feeding
- •do not consent to be in this study
- •allergies to interferon
- •not having a proper phone number for follow up calls
研究者
相似试验
招募中
3 期
Efficacy and safety of Interferon beta-1-a in mild to moderate COVID-19IRCT20120703010178N25Shahid Beheshti University of Medical Sciences100
已完成
3 期
Comparison of Interferon-beta-1a and Dexamethasone on hospitalized patients with Covid-19.IRCT20150622022869N9Yasouj University of Medical Sciences176
已完成
3 期
Efficacy and safety of peginterferon beta-1a (CinnaGen) in relapsing-remitting multiple sclerosis patients.Multiple sclerosis.Multiple sclerosisIRCT201612306135N8CinnaGen Pharmaceutical Company168
进行中（未招募）
不适用
The effect of interferon beta-1a treatment on adaptability of the brain in patients with MSMultiple sclerosisMedDRA version: 14.0Level: PTClassification code 10004504Term: Beta interferon therapySystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2011-003570-89-NLVU University Medical Center
招募中
2 期
Evaluation of the effect of Interferon Alfa-2b in diabetic macular edemaDiabetic macular edema.unspecified diabetic retinopathy with macular edemaE11. 311IRCT20230103057035N1Shahid Beheshti University of Medical Sciences49